Literature DB >> 11586227

The Spanish National Institutes of Health-Chronic Prostatitis Symptom Index: translation and linguistic validation.

M M Collins1, M P O'Leary, E A Calhoun, M A Pontari, A Adler, S Eremenco, C H Chang, L Odom, M S Litwin.   

Abstract

PURPOSE: The prominence of health related quality of life end points in international clinical research underscores the importance of well validated and translated measures to enable cross-cultural comparison. The National Institutes of Health (NIH)-Chronic Prostatitis Symptom Index (CPSI) assesses symptoms and health related quality of life in men with chronic nonbacterial, NIH type III prostatitis. To expand its use to Spanish speaking patients we performed a translation and linguistic validation.
MATERIALS AND METHODS: The 9-item NIH-CPSI was translated into Spanish according to a standard methodology of 2 forward translations, 1 reconciled version, back translation of the reconciled version and 3 independent reviews by bilingual experts. The purpose of this methodology was to create a single universal Spanish version that would be acceptable to native Spanish speakers inside and outside of the United States. After the translation process the Spanish version was pre-tested in Argentina, Mexico, Spain and the United States. Patient responses were analyzed to identify necessary modifications. The internal consistency of the CPSI was evaluated using Cronbach's alpha. Pearson's product moment correlations were used to evaluate construct validity.
RESULTS: Data were collected from chronic prostatitis patients, including 15 in Argentina, 15 in Mexico, 4 in the United States and 3 in Spain. The translation had high reliability overall and in all subscales (Cronbach's coefficient alpha = 0.81 to 0.94), and the subscales correlated well with each other (r = 0.76 to 0.97). However, patients expressed difficulty in distinguishing the response categories "a menudo" ("often") from "normalmente" ("usually") in question 3. We revised "a menudo" to "muchas veces" ("much of the time") and "normalmente" to "casi siempre" ("almost always") to improve the distinctiveness of response categories.
CONCLUSIONS: The Spanish NIH-CPSI has high reliability as well as face and construct validity in Spanish speaking men from various countries. The Spanish NIH-CPSI permits cross-cultural comparisons of men with chronic nonbacterial prostatitis.

Entities:  

Mesh:

Year:  2001        PMID: 11586227

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  12 in total

1.  Promoting pre-conceptional use of folic acid to Hispanic women: a social marketing approach.

Authors:  Gwendolyn P Quinn; Kimberlea Hauser; Bethany A Bell-Ellison; Nydia Y Rodriguez; Jaime L Frías
Journal:  Matern Child Health J       Date:  2006-06-03

2.  Category III chronic prostatitis/chronic pelvic pain syndrome: insights from the National Institutes of Health Chronic Prostatitis Collaborative Research Network studies.

Authors:  J Curtis Nickel; Richard B Alexander; Rodney Anderson; Richard Berger; Craig V Comiter; Nand S Datta; Jackson E Fowler; John N Krieger; J Richard Landis; Mark S Litwin; Mary McNaughton-Collins; Michael P O'Leary; Michel A Pontari; Anthony J Schaeffer; Daniel A Shoskes; Paige White; John Kusek; Leroy Nyberg
Journal:  Curr Urol Rep       Date:  2008-07       Impact factor: 3.092

3.  A potentially neuroprotective role for erythropoietin with paclitaxel treatment in ovarian cancer patients: a prospective phase II GINECO trial.

Authors:  Béatrice Weber; Rémy Largillier; Isabelle Ray-Coquard; Gabriel Yazbek; Jérôme Meunier; Jérôme Alexandre; Jérôme Dauba; Dominique Spaeth; Rémy Delva; Florence Joly; Eric Pujade-Lauraine; Laure Copel
Journal:  Support Care Cancer       Date:  2013-02-19       Impact factor: 3.603

Review 4.  Chronic prostatitis/chronic pelvic pain syndrome in elderly men: toward better understanding and treatment.

Authors:  Michel A Pontari
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 5.  Epidemiology of prostatitis.

Authors:  John N Krieger; Shaun Wen Huey Lee; Jeonseong Jeon; Phaik Yeong Cheah; Men Long Liong; Donald E Riley
Journal:  Int J Antimicrob Agents       Date:  2007-12-31       Impact factor: 5.283

6.  Reliability and validity of the National Institutes of Health: Chronic Prostatitis Symptom Index in a Malaysian population.

Authors:  Phaik Yeong Cheah; Men Long Liong; Kah Hay Yuen; Shaun Lee; Jin Rong Yang; Chu Leong Teh; Timothy Khor; Hin Wai Yap; John N Krieger
Journal:  World J Urol       Date:  2006-02-08       Impact factor: 4.226

7.  Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI).

Authors:  K J Propert; M S Litwin; Y Wang; R B Alexander; E Calhoun; J C Nickel; M P O'Leary; M Pontari; M McNaughton-Collins
Journal:  Qual Life Res       Date:  2006-03       Impact factor: 4.147

Review 8.  A systematic review of cross-cultural adaptation of the National Institutes of Health Chronic Prostatitis Symptom Index.

Authors:  Rong-Liang Dun; Jennifer Tsai; Xiao-Hua Hu; Jian-Min Mao; Wen-Jing Zhu; Guang-Chong Qi; Yu Peng
Journal:  Health Qual Life Outcomes       Date:  2021-05-31       Impact factor: 3.186

9.  Validity and reliability of the korean version of the MD anderson Dysphagia inventory for head and neck cancer patients.

Authors:  Chan-Hyuk Kwon; Yeo Hyung Kim; Jae Hyeon Park; Byung-Mo Oh; Tai Ryoon Han
Journal:  Ann Rehabil Med       Date:  2013-08-26

10.  Rescoring the NIH chronic prostatitis symptom index: nothing new.

Authors:  J Q Clemens; E A Calhoun; M S Litwin; M McNaughton-Collins; R L Dunn; E M Crowley; J R Landis
Journal:  Prostate Cancer Prostatic Dis       Date:  2009-06-02       Impact factor: 5.554

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.